Product
Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
1 clinical trial
2 indications
Indication
DiphtheriaIndication
Tetanus Acellular PertussisClinical trial
A Randomized, Blinded, Positive Vaccine-controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of DTcP in Infants and Children at 2 and 3 Months of AgeStatus: Active (not recruiting), Estimated PCD: 2024-08-01